News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Astellas Pharma Inc. Profit Slips 4.8%, Keeps Outlook
August 3, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Astellas Pharma Inc, Japan's second-largest drugmaker, reported on Monday a 4.8 percent drop in April-June recurring profit due to a strong yen.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Astellas Pharma US, Inc.
MORE ON THIS TOPIC
Manufacturing
Eli Lilly and Regeneron among 7 companies picked for FDA PreCheck pilot program
July 1, 2026
·
2 min read
·
Nick Paul Taylor
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
July 1, 2026
·
2 min read
·
Jef Akst
Business
Deep dive: Pharma CEO compensation report
June 30, 2026
·
1 min read
·
Annalee Armstrong
Layoff Tracker
BioCryst ends all internal discovery efforts
June 30, 2026
·
64 min read
·
BioSpace Editorial Staff
